Jupiter Research Capital (Asia) Ltd’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Jupiter Research Capital (Asia) Ltd's BLTE Position: Q2 2026 in Review
Jupiter Research Capital (Asia) Ltd sold out of Belite Bio (BLTE) in Q2 2026, closing a stake of 1,327 shares — an estimated $212K sold.
Jupiter Research Capital (Asia) Ltd first reported a position in BLTE in Q1 2026 and held it in 1 quarter. The position peaked at $212K in Q1 2026. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.
- Jupiter Research Capital (Asia) Ltd reported no remaining Belite Bio position as of Q2 2026 after selling out during the quarter.
- Jupiter Research Capital (Asia) Ltd sold 1,327 Belite Bio shares in Q2 2026, an estimated $212K.
- Jupiter Research Capital (Asia) Ltd first reported a position in Belite Bio in Q1 2026 and held it in 1 quarter.
- Jupiter Research Capital (Asia) Ltd's Belite Bio position peaked at $212K in Q1 2026.
- 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q2 2026, filed 16 Nov 2026.